Neuroophthalmological disorders associated with obstructive sleep apnoea (CROSBI ID 719558)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Kaštelan, Snježana ; Tomić, Zora ; Galić, Iva ; Bakija, Ivana ; Bogadi, Marija ; Čerfalvi, Iris ; Bišćan, Filip ; Galić, Edvard
engleski
Neuroophthalmological disorders associated with obstructive sleep apnoea
Sleep apnoea (SA) is the most common form of breathing disorder during sleep and is often associated with increased body weight. It causes recurrent pauses in breathing during sleep and transient nocturnal hypoxia and hypercapnia. The most common type accounting for over 85% of all SA cases is obstructive SA (OSA) characterized by repetitive episodes of upper airway obstruction during sleep. It is a condition with a high prevalence being estimated to affect 22–24% of men and 9–17% of women globally. Despite being a common disorder with increasing prevalence many cases still remain undiagnosed. OSA significantly impacts the quality of life and is recognized to cause various systemic changes including those on the eye and central nervous system. OSA has been identified as a significant risk factor for a number of neuro-ophthalmic conditions including non-arteritic anterior ischemic optic neuropathy (NAION). Patients with NAION have a significantly higher incidence of OSA, at the same time OSA diagnosis significantly increases the risk for NAION development. Evidence also suggests a connection between OSA and idiopathic intracranial hypertension (IIH), glaucoma and stroke. Treatment with continuous positive airway pressure (CPAP) has been seen to reverses some pathological changes, however with limited evidence. Whilst it is well established that OSA is associated with various neuroophthalmological disorders larger scale studies are necessary to investigate the role of OSA as a risk factor. OSA is under- recognized and ophthalmologists may be uniquely positioned to identify at-risk patients presenting with certain eye disorders. The role of treatment with CPAP, the reversibility of pathology as well as the long-term impact of OSA on health outcomes also need to be addressed.
obstructive sleep apnoea ; neuroophthalmological disorders ; non-arteritic anterior ischemic optic neuropathy ; idiopathic intracranial hypertension ; glaucoma ; stroke
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
30-31.
2022.
objavljeno
Podaci o matičnoj publikaciji
ABSTRACT BOOK 2022. 61st International Neuropsychiatric Congress Mind and Brain
Podaci o skupu
61. Međunarodni neuropsihijatrijski kongres (MIND & BRAIN)
predavanje
26.05.2022-29.05.2022
Pula, Hrvatska